Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumoursCorran Roberts, Shibani Nicum, Marcia Hall et al.|British Journal of Cancer|2019Cited by 14
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocolShibani Nicum, Susan Dutton, Corran Roberts et al.|BMC Cancer|2014Cited by 10